Genetic Cancer Risk Assessment: A Screenshot of the Psychosocial Profile of Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome
Affiliations
- PMID: 31984583
- DOI: 10.1002/pon.5305
Abstract
Objective: There is a lack of information describing Brazilian women at risk of hereditary breast and ovarian cancer syndrome (HBOC) who undergo genetic cancer risk assessment (GCRA). This study aims to characterize the psychosocial profile of women at risk for HBOC at their first GCRA to obtain an overview of their families' profiles and the challenges of the oncogenetics setting.
Methods: This was a cross-sectional study in which interviews were conducted with 83 cancer-affected women at their first GRCA appointment after the pedigree draw. Tools to evaluate psychological outcomes were applied. The pedigree genogram and ecomap were constructed and analyzed with content analysis using the "life course perspective" theory.
Results: Individuals perceived their breast/ovarian cancer risk to be equal to that of the general population, although they were highly concerned about developing cancer. No evidence of anxiety or depressive symptoms was identified. Participants used the coping strategy of searching for religiosity. The genograms and ecomaps resulted in five major themes: support and social support; attitudes, feelings and emotions; cancer causes; communication; and relationships with relatives. Individuals between 20-29 years of age and those with no family history of cancer tended not to communicate with relatives, which may indicate future problems in the GCRA process regarding genetic testing.
Conclusion: This study demonstrated that knowing the families who undergo the GCRA process can help professionals provide more individualized and thorough attention during GCRA and genetic testing, which results in better follow-up and prevention strategies. This article is protected by copyright. All rights reserved.
Keywords: cancer; genetic cancer risk assessment; genogram; hereditary breast and ovarian cancer; oncology.
This article is protected by copyright. All rights reserved.
Similar articles
- Prophylactic Oophorectomy: Reducing the U.S. Death Rate From Epithelial Ovarian Cancer. A Continuing DebateMS Piver. Oncologist 1 (5), 326-330. PMID 10388011.If instead of the title "Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer," the title were "Drug X Reducing the U.S. Death Rate from …
- Differences Between Women Who Pursued Genetic Testing for Hereditary Breast and Ovarian Cancer and Their At-Risk Relatives Who Did NotMC Katapodi et al. Oncol Nurs Forum 38 (5), 572-81. PMID 21875844.Significant differences exist between women who pursue genetic testing and those who do not. The family environment influences adjustment to HBOC and decisions about gene …
- Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study ProtocolMC Katapodi et al. JMIR Res Protoc 6 (9), e184. PMID 28931501.Robust evidence from basic science and descriptive population-based studies in Switzerland support the necessity of cascade screening for genetic predisposition to HBOC a …
- BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian CancerN Petrucelli et al. PMID 20301425. - ReviewGermline pathogenic variants in BRCA1 and BRCA2 are inherited in an autosomal dominant manner. The vast majority of individuals with a BRCA1 or BR …
- Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [Internet]HD Nelson et al. PMID 20722133. - ReviewThe evidence base for genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility as a screening strategy is limited by lack of …
No hay comentarios:
Publicar un comentario